The dose, route (intramuscular or slow intravenous, depending on the product), frequency, and duration of treatment are determined by a doctor based on the specific formulation, the severity of vitamin deficiency, the underlying condition, and the patients overall health
[PMID: 15103050] PubMed record related to this compound for laboratory literature review
B12 can hide some symptoms
PDR for Nutritional Supplements
When we have a clinical answer, we will make it available, with full transparency about what it does and does not do
[1] [2] This triple-receptor mechanism distinguishes it from currently approved agents such as semaglutide (a GLP-1 agonist) or tirzepatide (a dual GIP/GLP-1 agonist)